Home > Research > Publications & Outputs > IBD genetic risk profile in healthy first-degre...

Associated organisational unit

Electronic data

  • 209.full

    Rights statement: Copyright © Oxford University Press 2016

    Final published version, 777 KB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License


Text available via DOI:

View graph of relations

IBD genetic risk profile in healthy first-degree relatives of Crohn's disease patients

Research output: Contribution to Journal/MagazineJournal articlepeer-review

  • David Kevans
  • Mark S. Silverberg
  • Krzysztof Borowski
  • Anne Griffiths
  • Wei Xu
  • Venus Onay
  • Andrew D. Paterson
  • Jo Knight
  • Ken Croitoru
  • GEM Project
<mark>Journal publication date</mark>02/2016
<mark>Journal</mark>Journal of Crohn's and Colitis
Issue number2
Number of pages7
Pages (from-to)209-215
Publication StatusPublished
Early online date28/10/15
<mark>Original language</mark>English


BACKGROUND: Family history provides important information on risk of developing inflammatory bowel disease [IBD], and genetic profiling of first-degree relatives [FDR] of Crohn's disease [CD]- affected individuals might provide additional information. We aimed to delineate the genetic contribution to the increased IBD susceptibility observed in FDR.

METHODS: N = 976 Caucasian, healthy, non-related FDR; n = 4997 independent CD; and n = 5000 healthy controls [HC]; were studied. Genotyping for 158 IBD-associated single nucleotide polymorphisms [SNPs] was performed using the Illumina Immunochip. Risk allele frequency [RAF] differences between FDR and HC cohorts were correlated with those between CD and HC cohorts. CD and IBD genetic risk scores [GRS] were calculated and compared between HC, FDR, and CD cohorts.

RESULTS: IBD-associated SNP RAF differences in FDR and HC cohorts were strongly correlated with those in CD and HC cohorts, correlation coefficient 0.63 (95% confidence interval [CI] 0.53 - 0.72), p = 9.90 x 10(-19). There was a significant increase in CD-GRS [mean] comparing HC, FDR, and CD cohorts: 0.0244, 0.0250, and 0.0257 respectively [p < 1.00 x 10(-7) for each comparison]. There was no significant difference in the IBD-GRS between HC and FDR cohorts [p = 0.81]; however, IBD-GRS was significantly higher in CD compared with FDR and HC cohorts [p < 1.00 x 10(-10) for each comparison].

CONCLUSION: FDR of CD-affected individuals are enriched with IBD risk alleles compared with HC. Cumulative CD-specific genetic risk is increased in FDR compared with HC. Prospective studies are required to determine if genotyping would facilitate better risk stratification of FDR.